Click on the links below to preview selected pages from this course.
- Course Introduction
- Aspirin Therapy and Introduction to Aspirin Resistance
- Clopidogrel Therapy and Clopidogrel Resistance
- Platelets and Clopidogrel
- Clopidogrel Dosing
- Clopidogrel Resistance
- Which of the following is a receptor that is located on platelet cell membranes and is inhibited by clopidogrel, thereby preventing platelet aggregati...
- Antiplatelet Medication Response Testing: Specimen Collection and Handling Requirements
- Specimen Collection for Platelet Function Testing
- Specimen Processing for Platelet-Rich Plasma
- What is the recommended platelet count for a platelet-rich plasma sample, such as those prepared for light transmission aggregometry?
- Aspirin and Clopidogrel Response Testing
- Optical Light Transmission
- Aspirin Response Analysis: Optical Light Transmission Aggregometry
- Clopidogrel Response Analysis: Optical Light Transmittance Aggregometry
- Whole Blood Impedance Aggregometry
- Helena Laboratories PlateletWorks Kit
- Cartridge-Based Platelet Aggregation
- Aspirin Response Analysis: Cartridge-Based Platelet Aggregation
- Clopidogrel Response Analysis: P2Y12 Analysis
- Other Aspirin Response Tests
- Aspirin Response Analysis: Shear Flow Technology
- Aspirin Response Analysis: Urinary 11-Dehydrothromboxane B2 for Aspirin Resistance
- Aspirin Response Analysis: AspirinWorks Analysis
- A PFA-100 method system is used to evaluate platelet function in a patient who is on aspirin therapy. Which of the following collagen/epinephrine clos...
- The elevation of which of the following substances in a urine sample may indicate a decreased response to aspirin therapy and an increased potential f...
- Other Clopidogrel Response Tests
- Treatment for Antiplatelet Medication Resistant Patients
Level of instruction: Intermediate
Intended Audience: Medical laboratory scientists, medical technologists, and technicians. This course is also appropriate for medical laboratory science students and pathology residents.
Author information: Leah Coppolino, MPH, MLS(ASCP)CM is a Program Director at MediaLab, Inc. Previously, she was the Director of the Medical Laboratory Science Program at St. Christopher’s Hospital for Children in Philadelphia, Pennsylvania. She holds a Masters in Public Health from Thomas Jefferson University.
Reviewer information: Michael P. Ero, MLS(ASCP), CLS(CA), MBA is the Founder and President of Machaon Diagnostics, a clinical reference laboratory specializing in bleeding and clotting disorders. Michael has over three dozen publications in the field of thrombosis and hemostasis and has presented his work at national and international scientific meetings. He has been primary investigator on over 130 clinical trials and studies with physical, molecular, immunologic or hemostatic endpoints. He is currently an adjunct instructor at the School of Medical Technology at Michigan State University. He was previously the vice president of the Coagulation Center, Inc. of Oakland, California overseeing the delivery of comprehensive coagulation and platelet services. He has held past clinical- and research-focused positions with The Scripps Research Institute, Loyola University Medical Center and the University of Illinois, Chicago. He holds an MBA from Babson College in Wellesley, Massachusetts and a BS in Medical Technology from Michigan State University.
Reviewer information: Dr. Phyllis Ingham is the Director of Clinical Laboratory Technology Phlebotomy at West Georgia Technical College in Waco Georgia. Dr. Ingham holds a BS degree from Auburn University, a masters degree in education from Alabama State University, and a Doctorate in Educational Leadership from Argosy University. Dr. Ingham serves as District V Director for ASCLS-GA.